Japanese Pharmaceuticals & Biotech Potentially Undervalued Companies

Sumitomo Pharma

Market Cap: JP¥633.2b

Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.

Kissei Pharmaceutical

Market Cap: JP¥169.7b

Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan and internationally.

Ono Pharmaceutical

Market Cap: JP¥1.2t

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

Santen Pharmaceutical

Market Cap: JP¥603.7b

Engages in the research and development, production, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

Astellas Pharma

Market Cap: JP¥4.3t

Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.

Tsumura

Market Cap: JP¥280.8b

Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.

Shionogi

Market Cap: JP¥2.5t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.

Daito PharmaceuticalLtd

Market Cap: JP¥39.2b

Engages in the manufacture and sale of pharmaceutical products in Japan and internationally.

Zeria Pharmaceutical

Market Cap: JP¥94.9b

Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally.

Otsuka Holdings

Market Cap: JP¥6.4t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Takeda Pharmaceutical

Market Cap: JP¥9.2t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products.

Kidswell Bio

Market Cap: JP¥8.4b

Develops pharmaceutical products for the treatment of pediatric, pediatric, intractable, and Asia-endemic diseases in Japan.

GNI Group

Market Cap: JP¥183.3b

Engages in the research, development, manufacturing, and sale of pharmaceuticals and biomaterials in Japan, China, and the United States.

PeptiDream

Market Cap: JP¥143.3b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

WDB coco

Market Cap: JP¥6.2b

Provides outsourcing and support services for pharmaceutical and medical device development in Japan.

Fuji Pharma

Market Cap: JP¥48.2b

Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.

Astena Holdings

Market Cap: JP¥21.8b

Manufactures and sells medicine-related products in Japan.

ASKA Pharmaceutical HoldingsLtd

Market Cap: JP¥61.6b

Through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan.

Kaken Pharmaceutical

Market Cap: JP¥150.9b

Produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally.

Sawai Group Holdings

Market Cap: JP¥188.5b

Together with subsidiaries, engages in the manufacture and sale of pharmaceuticals.

Shin Nippon Biomedical Laboratories

Market Cap: JP¥59.0b

A contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally.

Daiichi Sankyo Company

Market Cap: JP¥5.2t

Manufactures and sells pharmaceutical products in Japan and internationally.

Chugai Pharmaceutical

Market Cap: JP¥11.5t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Nippon Shinyaku

Market Cap: JP¥247.2b

Manufactures and sells pharmaceuticals and foodstuffs in Japan, Europe, Switzerland, the United States, and internationally.

Kyowa Kirin

Market Cap: JP¥1.3t

Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.

Towa Pharmaceutical

Market Cap: JP¥191.7b

Manufactures and sale ethical drugs in Japan.

Healios K.K

Market Cap: JP¥36.5b

Engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.

atect

Market Cap: JP¥2.9b

Engages in the sanitation inspection equipment, powder injection molding (PIM), and semiconductor material businesses in Japan, South Korea, Taiwan, and internationally.